Campbell & Co Investment Adviser’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-78,116
Closed -$930K 1015
2026
Q1
$930K Buy
78,116
+68,051
+676% +$696K 0.05% 534
2025
Q4
$100K Sell
10,065
-718
-7% -$6.86K ﹤0.01% 1091
2025
Q3
$96.5K Sell
10,783
-9,936
-48% -$92K 0.01% 1044
2025
Q2
$195K Sell
20,719
-107,325
-84% -$947K 0.01% 1058
2025
Q1
$1.39M Sell
128,044
-5,499
-4% -$55.3K 0.11% 304
2024
Q4
$1.27M Buy
133,543
+19,658
+17% +$199K 0.1% 305
2024
Q3
$1.28M Buy
113,885
+30,789
+37% +$327K 0.1% 345
2024
Q2
$831K Buy
83,096
+37,561
+82% +$382K 0.07% 439
2024
Q1
$524K Buy
45,535
+31,505
+225% +$268K 0.05% 671
2023
Q4
$102K Buy
14,030
+3,035
+28% +$23.9K 0.01% 1062
2023
Q3
$100K Buy
+10,995
New +$132K 0.01% 897

Other funds holding AHCO

Campbell & Co Investment Adviser's AHCO Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of AdaptHealth (AHCO) in Q2 2026, closing a stake of 78,116 shares — an estimated $930K sold.

Campbell & Co Investment Adviser first reported a position in AHCO in Q3 2023 and held it in 11 quarters. The position peaked at $1.39M in Q1 2025. 51 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Campbell & Co Investment Adviser reported no remaining AdaptHealth position as of Q2 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 78,116 AdaptHealth shares in Q2 2026, an estimated $930K.
  • Campbell & Co Investment Adviser first reported a position in AdaptHealth in Q3 2023 and held it in 11 quarters.
  • Campbell & Co Investment Adviser's AdaptHealth position peaked at $1.39M in Q1 2025.
  • 51 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.